Insider Transactions Reported by 23 Insiders of Aclaris Therapeutics, Inc.

Symbol
ACRS on Nasdaq
Location
Wayne, PA

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Aclaris Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Braden M Leonard 10%+ Owner $17,731,275 02 Aug 2024
Neal Walker CEO, Director $5,376,123 03 Feb 2026
Anand Mehra Director $1,098,616 05 Jun 2025
ANDREW N. SCHIFF Director $691,011 05 Jun 2025
Joseph Monahan Chief Scientific Officer $550,792 01 Mar 2025
Kevin Balthaser Chief Financial Officer $542,716 01 Mar 2026
James Loerop Chief Business Officer $461,957 03 Feb 2026
Hugh M. Davis President and COO, Director $321,944 03 Feb 2026
Frank Ruffo Chief Financial Officer $211,977 10 Mar 2022
Kamil Ali-Jackson Chief Legal Officer $168,225 03 Jan 2022
David N. Gordon Chief Medical Officer $154,819 13 Jul 2021
Douglas J. Manion Pres and CEO, Director $128,954 01 Jan 2024
Christopher P. Molineaux Director $93,609 05 Jun 2025
Gail Cawkwell Chief Medical Officer $57,323 01 Jul 2023
William D. Humphries Director $56,230 05 Jun 2025
Andrew Kenneth William Powell Director $42,239 01 Jun 2024
MAXINE GOWEN Director $38,220 05 Jun 2025
Bryan M. Reasons Director $36,202 01 Jun 2024
VINCENT MILANO Director $31,430 05 Jun 2025
Foresite Capital Management III, LLC 10%+ Owner $8,690 01 Nov 2021
Jesse Wayne Hall Chief Medical Officer 02 Feb 2026
Biosion, Inc. 10%+ Owner 18 Nov 2024
Roland Wilhelm Kolbeck Chief Scientific Officer 02 Feb 2026

Recent Insider Transactions by Companies or Individuals for Aclaris Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.